نتائج البحث 161-170 من 8107 لعملية البحث عن Lymphoma red flag
Arushi Khurana, M.B.B.S.. Hematologist / Oncologist. Rochester, MN. مناطق التركيز: Chemotherapy, CAR-T cell therapy, Non-Hodgkin lymphoma, ...
This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...
Blood Cancers & Disorders Discussions. roberthall0452. Anyone else have Mantle Cell Lymphoma? 116 Replies Sun, Jul 26, 2026.
... lymphoma who have achieved a complete response after initial chemotherapy. A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma.
Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...
Luis F. Porrata, M.D.. Oncologist; Hematologist. Rochester, MN. مناطق التركيز: Cutaneous t-cell lymphoma, Sezary syndrome, B- ...
... lymphoma patients. Lymphoma is a diversified disease with outcomes differing upon the types and subtypes of lymphoma as well as treatment modalities used.
Fertility Outcomes in Lymphoma Patients. Jacksonville, Fla. The objectives of this study are to analyze impact of radiation on fertility, to correlate the ...
The purpose of this study is to compare the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden.
Blood Cancers & Disorders Discussions. roberthall0452. Anyone else have Mantle Cell Lymphoma? 117 Replies Mon, Jul 27, 2026.
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.